Type your tag names separated by a space and hit enter

Baloxavir

Edina Avdic, Pharm.D.
Baloxavir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of uncomplicated influenza, ages ≥ 12 years with symptoms < 48 hours.
    • Limitations of use: Consideration should be given to susceptibility patterns for circulating influenza virus strains when deciding whether to use baloxavir because viruses’ changing over time, virus type or subtype, the emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: January 17, 2019

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Baloxavir ID - 540707 A1 - Avdic,Edina,Pharm.D. Y1 - 2019/01/17/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540707/all/Baloxavir PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -